| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |